West Pharmaceuticals sees focusing in the delivery devices for biosimilars a critical to their new business plan. Not only is it a way to give differentiation to their biosimilars products, but as also expands the life of the profitability of the drugs they are administering. Read more here.
What do you think are the possibilities for drug delivery companies with the new for drug delivery companies now that approval of biosimiliars has a guidance? How much of a factor will safety of the biosimilars play into the approval of drug delivery devices for them?